[go: up one dir, main page]

AR026434A1 - Peptidos para el tratamiento de la disfuncion erectil. - Google Patents

Peptidos para el tratamiento de la disfuncion erectil.

Info

Publication number
AR026434A1
AR026434A1 ARP000105948A ARP000105948A AR026434A1 AR 026434 A1 AR026434 A1 AR 026434A1 AR P000105948 A ARP000105948 A AR P000105948A AR P000105948 A ARP000105948 A AR P000105948A AR 026434 A1 AR026434 A1 AR 026434A1
Authority
AR
Argentina
Prior art keywords
tryptophan
methyl
peptides
treatment
alanine
Prior art date
Application number
ARP000105948A
Other languages
English (en)
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of AR026434A1 publication Critical patent/AR026434A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07Tetrapeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/095Oxytocins; Vasopressins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen pequenos péptidos que provocan erecciones del pene en los animales machos cuando se inyectan en los nucleos paraventriculares del hipotálamo ocuando se administran sistémicamente (por vía intravenosa o subcutánea), a dichos animales. Est os péptidos resultan de utilidad para el tratamiento de ladisfunsion erectíl y tiene la siguiente formula: X-A-B-C-Y--NH2 en la cual X es alfa-aminoisobutirilo, tranexamilo (es decir, 4-(aminometilo)ciclohexancarbonilo); isonipecotinilo; gama- aminobu tirilo; hidrogeno o imidazolilacetilo, A es D-2-metil-triptofano, D-beta-(2-naftil) alanina; o D-triptofano;B es D-2-metil-triptofano; D-beta-(2-naftil) alanina; D-tripofano; o bien está ausente Ces D-2-metil-triptofano, fenilalanina; o está ausente; Y es lisina oarginina; donde D representa el dextro isomero; o una sal de adicion farmacéuticamente aceptable del péptido, en un nivel que tiene eficacia para provocar lacitada ereccion.
ARP000105948A 1999-11-10 2000-11-10 Peptidos para el tratamiento de la disfuncion erectil. AR026434A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/437,147 US6211156B1 (en) 1999-11-10 1999-11-10 Peptides for treatment of erectile dysfunction

Publications (1)

Publication Number Publication Date
AR026434A1 true AR026434A1 (es) 2003-02-12

Family

ID=23735278

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000105948A AR026434A1 (es) 1999-11-10 2000-11-10 Peptidos para el tratamiento de la disfuncion erectil.

Country Status (23)

Country Link
US (1) US6211156B1 (es)
EP (1) EP1246836A2 (es)
JP (1) JP2003513930A (es)
KR (1) KR20020058003A (es)
CN (1) CN1255426C (es)
AR (1) AR026434A1 (es)
AU (1) AU776994B2 (es)
BG (1) BG106735A (es)
BR (1) BR0015446A (es)
CA (1) CA2390854A1 (es)
CZ (1) CZ20021539A3 (es)
HK (1) HK1050205A1 (es)
HU (1) HUP0203181A3 (es)
IL (1) IL149200A0 (es)
MX (1) MXPA02004118A (es)
NO (1) NO20022101L (es)
NZ (1) NZ519062A (es)
PL (1) PL354613A1 (es)
RU (1) RU2264823C2 (es)
SK (1) SK6222002A3 (es)
UA (1) UA74170C2 (es)
WO (1) WO2001034171A2 (es)
ZA (1) ZA200203069B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10344848A1 (de) * 2003-09-26 2005-04-14 Solvay Pharmaceuticals Gmbh Amidomethyl-substituierte l-(Carboxyalkyl)-cyclopentylcarbonylamino-benzazepin-N-essigsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enhaltende Arzneimittel
RU2324703C1 (ru) * 2006-09-07 2008-05-20 Владимир Хацкелевич Хавинсон Пептидное соединение, стимулирующее функцию половой системы, фармацевтическая композиция на его основе и способ ее применения
CN101302246B (zh) * 2007-05-09 2011-05-11 中国人民解放军军事医学科学院毒物药物研究所 黑色素皮质激素受体七肽类激动剂及其制备方法和用途
RU2404793C1 (ru) 2009-06-04 2010-11-27 Общество с ограниченной ответственностью Био Пептид Стимулятор половой, сексуальной и репродуктивной функции
RU2507212C3 (ru) 2012-03-28 2022-05-04 Общество С Ограниченной Ответственностью "Айвикс" Способ получения рекомбинантного пептида и полученный пептид
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
RU2626002C1 (ru) 2016-10-24 2017-07-21 Общество С Ограниченной Ответственностью "Айвикс" Новая группа пептидов для лечения женской сексуальной дисфункции

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3943519A1 (de) * 1989-04-27 1991-01-17 Stief Georg Arzneimittel zur behandlung erektiler dysfunktionen
US5236904A (en) * 1989-09-18 1993-08-17 Senetek, Plc Erection-inducing methods and compositions
US5872100A (en) * 1990-05-11 1999-02-16 Deghenghi; Romano Peptides containing D-2-Alkyl-Tryptophan
DE69429768T2 (de) * 1993-04-05 2002-09-19 Competitive Technologies, Inc. Diagnose und behandlung von erektilen funktionsstörungen
EP0783521B8 (en) * 1994-09-27 2003-04-09 Ardana Bioscience Limited Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
CA2158425C (en) * 1995-09-15 2003-01-28 Mac E. Hadley Diagnostic and treatment of erectile dysfunction
IT1277113B1 (it) * 1995-12-20 1997-11-04 Romano Deghenghi Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita
US5807985A (en) * 1996-06-11 1998-09-15 Deghenghi; Romano Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone
US6124263A (en) * 1998-11-16 2000-09-26 Asta Medica Ag Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
US5932548A (en) * 1998-06-03 1999-08-03 Deghenghi; Romano Lysine containing peptides for treatment of heart disease

Also Published As

Publication number Publication date
AU776994B2 (en) 2004-09-30
PL354613A1 (en) 2004-02-09
RU2264823C2 (ru) 2005-11-27
KR20020058003A (ko) 2002-07-12
CZ20021539A3 (cs) 2003-08-13
IL149200A0 (en) 2002-11-10
WO2001034171A2 (en) 2001-05-17
SK6222002A3 (en) 2004-03-02
HUP0203181A2 (hu) 2003-02-28
BG106735A (bg) 2003-02-28
RU2002115662A (ru) 2004-01-27
US6211156B1 (en) 2001-04-03
UA74170C2 (uk) 2005-11-15
NZ519062A (en) 2003-10-31
JP2003513930A (ja) 2003-04-15
CN1390230A (zh) 2003-01-08
HUP0203181A3 (en) 2003-11-28
CA2390854A1 (en) 2001-05-17
EP1246836A2 (en) 2002-10-09
CN1255426C (zh) 2006-05-10
BR0015446A (pt) 2002-07-09
WO2001034171A3 (en) 2001-12-13
ZA200203069B (en) 2002-11-27
HK1050205A1 (zh) 2003-06-13
AU1278601A (en) 2001-06-06
MXPA02004118A (es) 2003-02-12
NO20022101D0 (no) 2002-05-02
NO20022101L (no) 2002-05-02

Similar Documents

Publication Publication Date Title
US5487898A (en) Compositions and method for the sublingual or buccal administration therapeutic agents
ES2259834T3 (es) Peptidos que contienen lisina para el tratamiento de la enfermedad coronaria.
KR970701730A (ko) GnRH 길항물질(GNRH ANTAGONISTS)
US6025471A (en) Diazaspiro, azepino and azabicyclo therapeutic peptides
CO5251429A1 (es) Derivados de ter-butil-(7-metil-imidazo(1,2-a)piridin-3- il)-amina procedimiento para su preparacion, medicamentos que los contienen, su uso para la preparacion de un medicamento para la inhibicion de la no-sintasa y composiciones farmaceuticas que l
BR0012080A (pt) Métodos e composições para administração intranasal de apomorfina
BR0012200B1 (pt) composição de peptídeo para o tratamento de disfunção sexual e composição farmacêutica para o tratamento de disfunção sexual em um mamífero.
HUP9802603A2 (hu) Lipofil peptid hormonszármazékok
KR950701818A (ko) 탈-tyr 다이놀핀 동족체(des-tyr dynorphin analogues)
PT95596A (pt) Processo para a preparacao de decapeptidos terapeuticos
AR026434A1 (es) Peptidos para el tratamiento de la disfuncion erectil.
AR047776A1 (es) Composiciones farmaceuticas glp - 1
CR7938A (es) Formulaciones parenterales de peptidos para el tratamiento de lupus eritematoso sistemico
PT91384A (pt) Processo para a preparacao de compostos farmaceuticos que compreendem um analogo peptidico da somatostatina
JP3810083B2 (ja) 成長因子の放出を促進し得る2−アルキルトリプトファン含有ペプチド化合物
DK0832107T3 (da) Forbedret peptid, immunogen sammensætning og vaccine eller medicinsk præparat, fremgangsmåde til immunisering af dyr mod hormonet LHRH samt analoge af LHRH-tandempeptid-gentagelsespeptidet og deres andvendelse som vaccine
PT80443B (en) Gnrh antagonists vii
WO2005018657A3 (en) NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY
RU97101109A (ru) Применение габапентина для лечения состояний страха и паники
JPH06206898A (ja) 血管作動性小腸ペプチドの新規誘導体
ES2291372T3 (es) Agonistas y antagonistas de urotensina-ii.
ES2167189A1 (es) Formulacion farmaceutica estable para la administracion intravenosa o intramuscular, de principios activos peptidicos
WO2005019457A3 (en) NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY
Kutina et al. Synthesis of new vasotocin analogues: effects on renal water and ion excretion in rats
Milne Ashgate handbook of endocrine agents and steroids

Legal Events

Date Code Title Description
FB Suspension of granting procedure